Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 24/Signature 1

From BugSigDB
Needs review

Curated date: 2024/11/11

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 12: Figure S12

Description: Differentially abundant taxa between the VANM group and Isoniazid treatment group.

Abundance in Group 1: increased abundance in H (Isoniazid)

NCBI Quality ControlLinks
Ethanoligenens
Arthrobacter
Butyricicoccus
Sporobacter
Acetanaerobacterium
Marvinbryantia
Erysipelotrichaceae
Thomasclavelia
Robinsoniella
Ruminococcus
Stomatobaculum
Christensenella
Pseudobacteroides
Eisenbergiella
Guggenheimella
Anaerotruncus
Anaerosporobacter
Dorea
Intestinimonas
Gordonibacter
Erysipelothrix
Roseburia
Acetatifactor
Romboutsia
Flavonifractor
Coprobacter
Enterorhabdus
Pediococcus
Pseudoflavonifractor
Dysgonomonas
Blautia
Anaerovorax
Barnesiella
Tyzzerella
Hydrogenoanaerobacterium
Alistipes
Akkermansia
Asaccharobacter
Mucispirillum
unclassified Eubacterium
Tannerella
Oscillibacter
Bacteroides
Lachnospiraceae

Revision editor(s): KateRasheed